Logo image of BEAT

HEARTBEAM INC (BEAT) Stock Fundamental Analysis

NASDAQ:BEAT - Nasdaq - US42238H1086 - Common Stock - Currency: USD

2.08  -0.03 (-1.42%)

After market: 2.1893 +0.11 (+5.25%)

Fundamental Rating

3

Taking everything into account, BEAT scores 3 out of 10 in our fundamental rating. BEAT was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While BEAT has a great health rating, there are worries on its profitability. BEAT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BEAT had negative earnings in the past year.
BEAT had a negative operating cash flow in the past year.
In the past 5 years BEAT always reported negative net income.
BEAT had a negative operating cash flow in each of the past 5 years.
BEAT Yearly Net Income VS EBIT VS OCF VS FCFBEAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M

1.2 Ratios

With a Return On Assets value of -276.70%, BEAT is not doing good in the industry: 96.81% of the companies in the same industry are doing better.
BEAT has a worse Return On Equity (-383.67%) than 84.57% of its industry peers.
Industry RankSector Rank
ROA -276.7%
ROE -383.67%
ROIC N/A
ROA(3y)-145.96%
ROA(5y)-1595.58%
ROE(3y)-223.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BEAT Yearly ROA, ROE, ROICBEAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K -4K -5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BEAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BEAT Yearly Profit, Operating, Gross MarginsBEAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

Compared to 1 year ago, BEAT has more shares outstanding
The number of shares outstanding for BEAT has been reduced compared to 5 years ago.
There is no outstanding debt for BEAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BEAT Yearly Shares OutstandingBEAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
BEAT Yearly Total Debt VS Total AssetsBEAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

BEAT has an Altman-Z score of -1.54. This is a bad value and indicates that BEAT is not financially healthy and even has some risk of bankruptcy.
BEAT has a Altman-Z score of -1.54. This is in the lower half of the industry: BEAT underperforms 60.11% of its industry peers.
There is no outstanding debt for BEAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.54
ROIC/WACCN/A
WACCN/A
BEAT Yearly LT Debt VS Equity VS FCFBEAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

BEAT has a Current Ratio of 3.31. This indicates that BEAT is financially healthy and has no problem in meeting its short term obligations.
BEAT's Current ratio of 3.31 is in line compared to the rest of the industry. BEAT outperforms 58.51% of its industry peers.
BEAT has a Quick Ratio of 3.31. This indicates that BEAT is financially healthy and has no problem in meeting its short term obligations.
BEAT has a better Quick ratio (3.31) than 70.21% of its industry peers.
Industry RankSector Rank
Current Ratio 3.31
Quick Ratio 3.31
BEAT Yearly Current Assets VS Current LiabilitesBEAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.55% over the past year.
EPS 1Y (TTM)43.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.15%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 6.82% on average over the next years.
Based on estimates for the next years, BEAT will show a very strong growth in Revenue. The Revenue will grow by 350.11% on average per year.
EPS Next Y20.79%
EPS Next 2Y19.6%
EPS Next 3Y6.82%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y1119.79%
Revenue Next 3Y350.11%
Revenue Next 5YN/A

3.3 Evolution

BEAT Yearly Revenue VS EstimatesBEAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
BEAT Yearly EPS VS EstimatesBEAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BEAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BEAT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BEAT Price Earnings VS Forward Price EarningsBEAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BEAT Per share dataBEAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.6%
EPS Next 3Y6.82%

More info and screens

0

5. Dividend

5.1 Amount

BEAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HEARTBEAM INC

NASDAQ:BEAT (2/21/2025, 8:03:04 PM)

After market: 2.1893 +0.11 (+5.25%)

2.08

-0.03 (-1.42%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-20 2025-03-20/amc
Inst Owners8.09%
Inst Owner Change-82.2%
Ins Owners10.57%
Ins Owner Change-0.4%
Market Cap55.47M
Analysts80
Price Target5.1 (145.19%)
Short Float %1.5%
Short Ratio1.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9.67%
Min EPS beat(2)-12.89%
Max EPS beat(2)-6.44%
EPS beat(4)0
Avg EPS beat(4)-10.36%
Min EPS beat(4)-12.89%
Max EPS beat(4)-6.44%
EPS beat(8)2
Avg EPS beat(8)-10.77%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)2.56%
EPS NQ rev (3m)-2.7%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 11.55
P/tB 11.55
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS0
BVpS0.18
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -276.7%
ROE -383.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-145.96%
ROA(5y)-1595.58%
ROE(3y)-223.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.31
Quick Ratio 3.31
Altman-Z -1.54
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.15%
EPS Next Y20.79%
EPS Next 2Y19.6%
EPS Next 3Y6.82%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y1119.79%
Revenue Next 3Y350.11%
Revenue Next 5YN/A
EBIT growth 1Y-27.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.73%
OCF growth 3YN/A
OCF growth 5YN/A